XGN (Exagen Inc. Common Stock)
Insider Trading Activity
Every open-market purchase and sale reported by XGN officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-02 | Jeffrey G. Black | Chief Financial Officer | MIXED | — | — |
| 2026-08-24 | Bruce C Robertson | Director | A | — | — |
| 2026-08-19 | Paul Kim | Director | A | — | — |
| 2026-08-19 | Bruce C Robertson | Director | A | — | — |
| 2026-06-22 | Frank Stokes | Director | A | — | — |
| 2026-06-22 | Chas McKhann | Director | A | — | — |
| 2026-06-22 | SCOTT D KAHN | Director | A | — | — |
| 2026-03-16 | JOHN ABALLI | President and CEO | A | — | — |
| 2026-03-16 | Jeffrey G. Black | Chief Financial Officer | A | — | — |
| 2026-03-04 | JOHN ABALLI | President and CEO | MIXED | — | — |
| 2026-02-25 | Jeffrey G. Black | Chief Financial Officer | Sell | — | — |
| 2026-02-25 | JOHN ABALLI | President and CEO | Sell | — | — |
| 2025-10-20 | JOHN ABALLI | President and CEO | Sell | — | — |
| 2025-09-04 | Jeffrey G. Black | Chief Financial Officer | Sell | — | — |
| 2025-06-12 | Ana Hooker | Director | A | — | — |
| 2025-06-12 | SCOTT D KAHN | Director | A | — | — |
| 2025-06-12 | Paul Kim | Director | A | — | — |
| 2025-06-12 | Frank Stokes | Director | A | — | — |
| 2025-06-12 | Paul Kim | Director | A | — | — |
| 2025-06-12 | Tina Susan Nova | Director | A | — | — |
| 2025-03-27 | Sun Mountain Capital Partners LLC | 10%+ Owner | Sell | — | — |
| 2025-03-04 | JOHN ABALLI | President and CEO | A | — | — |
| 2025-02-25 | JOHN ABALLI | President and CEO | — | — | — |
| 2025-02-25 | JOHN ABALLI | President and CEO | A | — | — |
| 2025-02-25 | Jeffrey G. Black | Chief Financial Officer | A | — | — |
| 2024-11-27 | Sun Mountain Capital Partners LLC | 10%+ Owner | Sell | — | — |
| 2024-11-19 | Jeffrey G. Black | Chief Financial Officer | Buy | — | — |
| 2024-11-18 | JOHN ABALLI | President and CEO | Buy | — | — |
| 2024-09-04 | Jeffrey G. Black | Chief Financial Officer | A | — | — |
| 2024-06-14 | SCOTT D KAHN | Director | A | — | — |
| 2024-06-12 | Ana Hooker | Director | A | — | — |
| 2024-06-12 | Frank Stokes | Director | A | — | — |
| 2024-06-12 | Paul Kim | Director | A | — | — |
| 2024-06-12 | Tina Susan Nova | Director | A | — | — |
| 2024-05-16 | JOHN ABALLI | President and CEO | Buy | — | — |
| 2024-03-06 | Kamal Adawi | CFO and Corporate Secretary | Sell | — | — |
| 2024-03-04 | JOHN ABALLI | President and CEO | A | — | — |
| 2024-02-22 | Kamal Adawi | CFO and Corporate Secretary | A | — | — |
| 2024-02-22 | JOHN ABALLI | President and CEO | A | — | — |
| 2024-02-08 | Kamal Adawi | CFO and Corporate Secretary | Sell | — | — |
| 2023-10-18 | JOHN ABALLI | President and CEO | Sell | — | — |
| 2023-09-06 | JOHN ABALLI | President and CEO | A | — | — |
| 2023-07-26 | Paul Kim | Director | A | — | — |
| 2023-06-20 | Tina Susan Nova | Executive Chairperson | A | — | — |
| 2023-06-20 | TULLIS GROWTH FUND II, L.P. | 10%+ Owner | Buy | — | — |
| 2023-06-13 | Wendy S. Johnson | Director | A | — | — |
| 2023-06-13 | Brian Birk | Director | A | — | — |
| 2023-06-13 | Frank Stokes | Director | A | — | — |
| 2023-06-13 | EBETUEL PALLARES | Director | A | — | — |
| 2023-06-13 | Ana Hooker | Director | A | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | 10%+ Owner | 1,789,585 | — |
| — | 10%+ Owner | 1,758,958 | — |
| — | 10%+ Owner | 1,696,252 | — |
| — | 10%+ Owner | 1,312,991 | — |
| — | 10%+ Owner | 1,289,345 | — |
| — | President and CEO | 880,235 | — |
| — | 10%+ Owner | 381,722 | — |
| — | Chief Financial Officer | 323,339 | — |
| — | CFO and Corporate Secretary | 243,749 | — |
| — | Chief Business Officer | 190,205 | — |
| — | President and CEO | 120,678 | — |
| — | Chief Medical Officer | 84,259 | — |
| — | Director | 25,885 | — |
| — | 10%+ Owner | 22,779 | — |
| — | Director | 1,185 | — |
| — | Director | 1,000 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the XGN quote page; the site-wide leaderboard is on the insider transactions hub.